Related references
Note: Only part of the references are listed.VentX, a Novel Lymphoid-Enhancing Factor/T-Cell Factor-Associated Transcription Repressor, Is a Putative Tumor Suppressor
Hong Gao et al.
CANCER RESEARCH (2010)
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
T. D. Shanafelt et al.
LEUKEMIA (2010)
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
Emanuela Rosati et al.
BLOOD (2009)
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Asish K. Ghosh et al.
BLOOD (2009)
Brief Report: Natural History of Individuals With Clinically Recognized Monoclonal B-Cell Lymphocytosis Compared With Patients With Rai 0 Chronic Lymphocytic Leukemia
Tait D. Shanafelt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia
Ola Landgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway
Desheng Lu et al.
PLOS ONE (2009)
A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis
Konstantin Petropoulos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Pathogenesis and progression of monoclonal gammopathy of undetermined significance
J. Blade et al.
LEUKEMIA (2008)
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis
Weidong Zhu et al.
NATURE (2008)
Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia
Andy C. Rawstron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas
Christina Spaulding et al.
BLOOD (2007)
Mastermind-like 1 is a specific coactivator of β-catenin transcription activation and is essential for colon carcinoma cell survival
Marie-Clotilde Alves-Guerra et al.
CANCER RESEARCH (2007)
Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells
Jaime R. Darce et al.
JOURNAL OF IMMUNOLOGY (2007)
Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia
Neil E. Kay et al.
BLOOD (2007)
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells
BT Messmer et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia
DS Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis
J Galceran et al.
GENES & DEVELOPMENT (2004)
Faster cyclic loess: normalizing RNA arrays via linear models
KV Ballman et al.
BIOINFORMATICS (2004)
Monoclonal B lymphocytes with the characteristics of indolent chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts
AC Rawstron et al.
BLOOD (2002)
ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation
FT Kolligs et al.
CANCER CELL (2002)
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells
U Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The notch intracellular domain can function as a coactivator for LEF-1
DA Ross et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
β-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
K Hovanes et al.
NATURE GENETICS (2001)
The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing
K Hovanes et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
